| Literature DB >> 30223456 |
Carlos Escott1, Antonio Morata2, Jorge M Ricardo-da-Silva3, María Jesús Callejo4, María Del Carmen González5, José Antonio Suarez-Lepe6.
Abstract
Anthocyanins in red grape musts may evolve during the winemaking process and wine aging for several different reasons; colour stability and evolution is a complex process that may depend on grape variety, winemaking technology, fermentative yeast selection, co-pigmentation phenomena and polymerization. The condensation of flavanols with anthocyanins may occur either with the flavylium ion or with the hemiacetal formation in order to produce oligomers and polymers. The kinetics of the reaction are enhanced by the presence of metabolic acetaldehyde, promoting the formation of pyranoanthocyanin-type dimers or flavanol-ethyl-anthocyanin structures. The experimental design carried out using white must corrected with the addition of malvidin-3-O-glucoside and flavanols, suggests that non-Saccharomyces yeasts are able to provide increased levels of colour intensity and larger polymeric pigment ratios and polymerization indexes. The selection of non-Saccharomyces genera, in particular Lachancea thermotolerans and Schizosaccharomyces pombe in sequential fermentation, have provided experimental wines with increased fruity esters, as well as producing wines with potential pigment compositions, even though there is an important reduction of total anthocyanins.Entities:
Keywords: flavanols; malvidin; non-Saccharomyces; polymeric pigments; red wine
Mesh:
Substances:
Year: 2018 PMID: 30223456 PMCID: PMC6225490 DOI: 10.3390/molecules23092353
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Yeast population growth. Data from acetaldehyde and pyruvic acid concentrations during fermentation. Analyses performed with gas chromatography (GC-FID) (acetaldehyde), enzymatic analyser (pyruvic acid) and plate counting (cells growth). Each point represents mean values (n = 3). Dotted lines indicate the sequential yeast inoculation. (A) CAT, (B) PB2, (C) PC1 and (D) PA2.
Ethanol, acidity and sugar content in wine samples. Results are shown by treatment. The statistical analysis was performed by parameter (columns) and the different letters indicate significant statistical difference (LSD method with method with 95% confidence level). Means ± standard deviation (STD) (n = 3).
| Treatment | EtOH | pH | Malic Acid | Volatile Acidity | Lactic Acid | Total Acidity | Glucose | Fructose |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Sc | 14.2 ± 0.2 a | 3.6 ± 0.0 c | 2.0 ± 0.1 ab | 0.6 ± 0.0 ab | 0.5 ± 0.1 b | 5.1 ± 0.0 a | 0.9 ± 0.2 b | 2.0 ± 0.1 b |
| Lt-Sc | 14.0 ± 0.2 a | 3.6 ± 0.0 c | 1.7 ± 0.1 d | 0.2 ± 0.0 c | 0.8 ± 0.1 a | 4.9 ± 0.1 bc | 0.8 ± 0.1 b | 1.2 ± 0.2 b |
| Lt-Sp | 13.7 ± 0.1 a | 3.8 ± 0.0 a | 0.7 ± 0.1 f | 0.2 ± 0.0 c | 0.8 ± 0.1 a | 3.4 ± 0.1 d | 3.5 ± 0.2 a | 10.8 ± 0.8 a |
|
| ||||||||
| Sc | 14.2 ± 0.1 a | 3.6 ± 0.0 c | 2.0 ± 0.1 abc | 0.6 ± 0.0 b | 0.6 ± 0.1 b | 5.1 ± 0.1 ab | 0.9 ± 0.1 b | 1.5 ± 0.2 b |
| Lt-Sc | 14.0 ± 0.3 a | 3.6 ± 0.0 c | 1.7 ± 0.0 d | 0.2 ± 0.0 c | 0.7 ± 0.0 a | 4.8 ± 0.1 c | 0.9 ± 0.1 b | 1.3 ± 0.1 b |
| Lt-Sp | 13.8 ± 0.3 a | 3.8 ± 0.0 a | 0.7 ± 0.0 f | 0.2 ± 0.0 c | 0.7 ± 0.0 a | 3.4 ± 0.1 d | 3.1 ± 0.5 a | 10.2 ± 0.8 a |
|
| ||||||||
| Sc | 14.2 ± 0.2 a | 3.7 ± 0.0 bc | 2.1 ± 0.1 a | 0.6 ± 0.1 ab | 0.5 ± 0.0 b | 5.2 ± 0.1 a | 1.0 ± 0.2 b | 2.6 ± 1.1 b |
| Lt-Sc | 14.4 ± 0.1 a | 3.6 ± 0.0 c | 1.8 ± 0.2 bcd | 0.2 ± 0.0 c | 0.8 ± 0.1 a | 4.8 ± 0.1 c | 1.0 ± 0.2 b | 1.8 ± 0.7 b |
| Lt-Sp | 13.9 ± 0.3 a | 3.8 ± 0.0 ab | 0.6 ± 0.1 f | 0.2 ± 0.0 c | 0.8 ± 0.1 a | 3.4 ± 0.1 d | 2.8 ± 0.8 a | 10.1 ± 0.7 a |
|
| ||||||||
| Sc | 14.1 ± 0.2 a | 3.6 ± 0.0 c | 2.0 ± 0.1 abc | 0.7 ± 0.0 a | 0.5 ± 0.0 b | 5.2 ± 0.1 a | 0.7 ± 0.2 b | 1.8 ± 0.5 b |
| Lt-Sc | 14.1 ± 0.1 a | 3.6 ± 0.0 c | 1.7 ± 0.1 cd | 0.2 ± 0.0 c | 0.9 ± 0.0 a | 4.9 ± 0.0 c | 1.0 ± 0.1 b | 1.6 ± 0.3 b |
| Lt-Sp | 13.7 ± 0.2 a | 3.8 ± 0.0 a | 0.7 ± 0.1 f | 0.2 ± 0.0 c | 0.9 ± 0.1 a | 3.5 ± 0.1 d | 3.3 ± 0.4 a | 11.0 ± 0.9 a |
CAT. (+)-catechin, PB 2: procyanidin B2, PC 1: procyanidin C1, PA 2: procyanidin A2.
Summary of fermentative volatile compounds quantified by GC-FID. The statistical analysis is given by parameter (columns) and the difference in letters indicates significant statistical difference (LSD method with 95% confidence level). Means ± STD (n = 3).
| Treatment | Higher Alcohols 1
| Carbonyl Compounds 2 | Fruity Esters 3 | Total Volatiles |
|---|---|---|---|---|
|
| ||||
| Sc | 135.9 ± 4.4 f | 42.0 ± 1.7 c | 8.7 ± 0.6 c | 1316.6 ± 91,4 c |
| Lt-Sc | 253.9 ± 8.3 a | 59.8 ± 1.9 a | 15.8 ± 0.4 b | 1048.6 ± 11.2 d |
| Lt-Sp | 196.1 ± 1.7 c | 38.4 ± 0.6 cd | 27.1 ± 1.2 a | 933.5 ± 7.4 e |
|
| ||||
| Sc | 154.9 ± 4.1 e | 46.7 ± 0.8 b | 8.4 ± 0,9 c | 1615.7 ± 64.0 b |
| Lt-Sc | 227.7 ± 5.3 b | 62.2 ± 1.5 a | 14.7 ± 0.4 b | 1028.1 ± 9.1 de |
| Lt-Sp | 203.0 ± 5.6 c | 36.6 ± 1.5 d | 23.6 ± 0.7 a | 987.7 ± 7.4 de |
|
| ||||
| Sc | 137.3 ± 1.0 f | 36.8 ± 0.6 d | 7.5 ± 0.6 c | 1421.5 ± 53.5 c |
| Lt-Sc | 233.7 ± 3.8 b | 58.3 ± 1.0 a | 14.0 ± 0.7 b | 1047.9 ± 11.7 de |
| Lt-Sp | 209.2 ± 4.8 c | 36.5 ± 1.0 d | 24.6 ± 0.5 a | 981.7 ± 34.4 de |
|
| ||||
| Sc | 179.8 ± 4.6 d | 50.5 ± 0.8 b | 8.8 ± 0.4 c | 1746.0 ± 16.0 a |
| Lt-Sc | 232.0 ± 7.6 b | 58.4 ± 1.9 a | 17.7 ± 1.6 b | 1033.4 ± 18.3 de |
| Lt-Sp | 206.8 ± 2.9 c | 38.4 ± 1.8 cd | 27.2 ± 1.7 a | 1022.0 ± 15.1 de |
1 Higher alcohols comprise the following compounds: 1-propanol, 2-buntanol, isobutanol, 1-butanol, 2-methyl-1-butanol, 3-methyl-1-butanol,2-phenylethylalcohol; 2 Carbonyl compounds comprise: diacetyl, acetoin, ethyl acetate; and 3 Fruity esters comprise: isobutyl acetate, ethyl butyrate, ethyl lactate, isoamyl acetate, 2-phenylethyl acetate.
Summary of pigments found in experimental red wines. The statistical analysis is given by parameter (columns) and the difference in letters indicates significant statistical difference (LSD method with 95% confidence level). Means ± STD (n = 3).
| Treatment | Malvidin 1 | Vitisins | Vinylphenolics | Oligomeric Pigments 2 |
|---|---|---|---|---|
|
| ||||
| Sc | 28.7 ± 1.8 b | 0.1 ± 0.0 abc | 0.3 ± 0.0 ab | 1.0 ± 0.1 a |
| Lt-Sc | 25.9 ± 0.8 c | 0.1 ± 0.0 bc | 0.2 ± 0.0 e | 0.8 ± 0.0 b |
| Lt-Sp | 14.0 ± 0.7 d | 0.1 ± 0.0 abc | 0.0 ± 0.0 f | 0.6 ± 0.1d |
|
| ||||
| Sc | 29.7 ± 0.3 ab | 0.1 ± 0.0 ab | 0.4 ± 0.1 a | 0.7 ± 0.0 cd |
| Lt-Sc | 26.7 ± 0.6 c | 0.0 ± 0.0 c | 0.2 ± 0.0 cd | 0.6 ± 0.0 d |
| Lt-Sp | 14.7 ± 1.3 d | 0.1 ± 0.0 abc | 0.0 ± 0.0 f | 0.6 ± 0.0 d |
|
| ||||
| Sc | 30.8 ± 0.5 a | 0.1 ± 0.0 a | 0.2 ± 0.0 bc | 0.7 ± 0.0 c |
| LtSc | 26.4 ± 0.3 c | 0.1 ± 0.0 abc | 0.2 ± 0.0 de | 0.6 ± 0.1 cd |
| LtSp | 13.7 ± 0.6 d | 0.0 ± 0.0 bc | 0.0 ± 0.0 f | 0.4 ± 0.0 e |
|
| ||||
| Sc | 29.9 ± 0.5 ab | 0.1 ± 0.0 abc | 0.3 ± 0.1 a | 0.6 ± 0.1d |
| LtSc | 26.4 ± 0.3 c | 0.0 ± 0.0 bc | 0.2 ± 0.0 d | 0.4 ± 0.0 e |
| LtSp | 14.3 ± 0.6 d | 0.0 ± 0.0 bc | 0.0 ± 0.0 f | 0.4 ± 0.0 e |
1 Comprises the content of malvidin-3-O-glucoside and its derivative malvidin-3-O-(6-p-coumaroylglucoside). 2 Comprises the content of identified polymeric pigments and unidentified peaks described in Table 4. CAT: (+)-catechin, PB2: procyanidin B2, PC1: procyanidin C1, PA2: procyanidin A2.
Pigments identified with HPLC-DAD-ESI/MS with DAD signal at 525nm.
| Compound | tR | [M]+
| Fragment | λ max-vis | Reference |
|---|---|---|---|---|---|
| Malvidin-3- | 12.9 | 781 | 619 | 530 | [ |
| Unidentified Peak 1 | 13.4 | 679 | - | 514 | |
| Malvidin-3- | 13.9 | 931 | - | 533 | [ |
| Malvidin-3- | 14.2 | 809 | - | 538 | [ |
| Unidentified Peak 2 | 14.3 | 995 | 782 | 538 | |
| Malvidin-3- | 14.5 | 954 | 852 | 520 | [ |
| Malvidin-3- | 14.6 | 809 | 643 | 542 | [ |
| Malvidin-3- | 14.9 | 805 | 331 | 540 | [ |
| Malvidin-3- | 15.3 | 809 | 643 | 538 | [ |
| Diepicatechin-malvidin-3- | 16.2 | 1069 | 619 | 506 | [ |
| Unidentified Peak 3 | 17.3 | 829 | 691 | 512 |
(tR) retention time; ([M]+) molecular ion; (λ) maximum absorption wavelength.
Figure 2Principal Component Analysis (PCA) for pigments determination in experimental trials. The clusters identified correspond to the fermentative yeasts used (block font). The numbers refer to each of the four treatments assessed: (1) CAT; (2) PB2; (3) PC1, and; (4) PA2.
Results from UV-Vis determination of colour parameters and polyphenols. The statistical analysis is given by parameter (columns) and the difference in letters indicates significant statistical difference (LSD method with 95% confidence level). Means ± STD (n = 3).
| Treatment | I | N | ± % | TPI | ChA | PI | PP | TP |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Sc | 0.78 ± 0.0 bc | 1.59 ± 0.0 c | 17.76 ± 0.8 bc | 13.81 ± 0.1 b | 0.13 ± 0.0 bc | 12.77 ± 0.6 de | 0.13 ± 0.0 bc | 1.03 ± 0.1 a |
| Lt-Sc | 0.80 ± 0.0 ab | 1.65 ± 0.0 c | 30.84 ± 1.8 a | 13.41 ± 0.1 b | 0.23 ± 0.0 a | 23.12 ± 0.6 ab | 0.15 ± 0.0 a | 0.66 ± 0.0 d |
| Lt-Sp | 0.82 ± 0.0 ab | 2.25 ± 0.0 ab | 23.53 ± 3.6 b | 14.77 ± 0.1 a | 0.25 ± 0.0 a | 25.27 ± 2.2 a | 0.15 ± 0.0 a | 0.59 ± 0.0 d |
|
| ||||||||
| Sc | 0.71 ± 0.1 d | 1.59 ± 0.0 c | 16.39 ± 0.2 c | 13.70 ± 0.5 b | 0.12 ± 0.0 c | 11.80 ± 0.7 e | 0.12 ± 0.0 c | 1.02 ± 0.1 ab |
| Lt-Sc | 0.81 ± 0.0 ab | 1.64 ± 0.0 c | 22.86 ± 2.2 bc | 13.39 ± 0.0 b | 0.19 ± 0.0 b | 19.17 ± 1.1 bc | 0.16 ± 0.0 a | 0.82 ± 0.1 c |
| Lt-Sp | 0.84 ± 0.0 a | 2.17 ± 0.0 b | 22.68 ± 4.2 bc | 15.04 ± 0.2 a | 0.25 ± 0.0 a | 24.61 ± 1.3 a | 0.16 ± 0.0 a | 0.64 + 0.1 d |
|
| ||||||||
| Sc | 0.74 ± 0.0 cd | 1.64 ± 0.0 c | 18.49 ± 1.6 bc | 13.61 ± 0.1 b | 0.13 ± 0.0 bc | 12.84 ± 0.6 de | 0.12 ± 0.0 c | 0.95 ± 0.1 b |
| Lt-Sc | 0.80 ± 0.0 ab | 1.65 ± 0.0 c | 22.48 ± 1.2 bc | 13.36 ± 0.1 b | 0.18 ± 0.0 b | 18.44 ± 0.4 c | 0.15 ± 0.0 a | 0.82 ± 0.0 c |
| Lt-Sp | 0.84 ± 0.0 a | 2.20 ± 0.1 ab | 24.53 ± 2.9 ab | 14.64 ± 0.3 a | 0.27 ± 0.0 a | 26.70 ± 2.7 a | 0.16 ± 0.0 a | 0.59 ± 0.0 d |
|
| ||||||||
| Sc | 0.75 ± 0.0 cd | 1.64 ± 0.0 c | 20.60 ± 1.2 bc | 13.81 ± 0.1 b | 0.16 ± 0.0 ab | 15.84 ± 0.7 cd | 0.14 ± 0.0 b | 0.85 ± 0.0 c |
| Lt-Sc | 0.82 ± 0.0 ab | 1.66 ± 0.0 c | 23.22 ± 2.5 b | 13.38 ± 0.2 b | 0.19 ± 0.0 b | 19.05 ± 1.9 c | 0.16 ± 0.0 a | 0.82 ± 0.1 c |
| Lt-Sp | 0.84 ± 0.0 a | 2.26 ± 0.0 a | 21.77 ± 2.0 bc | 14.86 ± 0.2 a | 0.25 ± 0.0 a | 25.31 ± 0.9 a | 0.16 ± 0.0 a | 0.62 ± 0.0 d |
I: Colour intensity; N: Hue (N); α: anthocyanin ionization degree; TPI: total polyphenols index; ChA: chemical age; PI: polymerization index; PP: polymerized pigments; TP: total pigments.
Pearson correlation plot for pigments and colour indexes. X indicates values not significant at 5%. P-values below 0.05 indicate statistically significant non-zero correlations. R values = +0.7 or higher indicate very strong positive relationship while, R values = −0.7 or higher indicate very strong negative relationship.
| Malvidin | Vitisin | Vinyphenolics | Oligomers | I | N | α | TPI | ChA | PI | PP | TP | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| X | 0.930 | X | −0.799 | −0.979 | X | −0.890 | −0.906 | −0.900 | −0.660 | 0.872 | |
|
| X | X | 0.704 | X | X | X | X | X | X | −0.633 | X | |
|
| 0.930 | X | X | −0.848 | −0.920 | X | −0.783 | −0.901 | −0.898 | −0.696 | 0.889 | |
|
| X | 0.704 | X | X | X | X | X | X | X | −0.645 | X | |
|
| −0.799 | X | −0.848 | X | 0.701 | 0.602 | X | 0.878 | 0.882 | 0.920 | −0.816 | |
|
| −0.979 | X | −0.920 | X | 0.701 | X | 0.939 | 0.841 | 0.834 | X | −0.826 | |
|
| X | X | X | X | 0.602 | X | X | 0.711 | 0.720 | 0.667 | −0.733 | |
|
| −0.890 | X | −0.783 | X | X | 0.939 | X | 0.672 | 0.654 | X | −0.649 | |
|
| −0.906 | X | −0.901 | X | 0.878 | 0.841 | 0.711 | 0.672 | 0.999 | 0.833 | −0.985 | |
|
| −0.900 | X | −0.898 | X | 0.882 | 0.834 | 0.720 | 0.654 | 0.999 | 0.840 | −0.987 | |
|
| −0.660 | −0.633 | −0.696 | −0.645 | 0.920 | X | 0.667 | X | 0.833 | 0.840 | −0.788 | |
|
| 0.872 | X | 0.889 | X | −0.816 | −0.826 | −0.733 | −0.649 | −0.985 | −0.987 | −0.788 |
I: Colour intensity; N: Hue (N); α: anthocyanin ionization degree; TPI: total polyphenols indeX; ChA; chemical age; PI: polymerization indeX; PP: polymerized pigments; TP: total pigments.
Figure 3EXperimental design for CAT treatment. Three different trials named Lt-Sc, Lt-Sp and Sc resulted from the combination of 1st and 2nd phase yeast. The other treatments assessed (PB2, PC1, and PA2) followed the same design.